RASSF10 and hepatocellular carcinoma: Some reports have showed the reduced expression of RASSF10 was significantly associated with the advanced tumor stage in prostate carcinoma and glioma.18, 19 Our in vitro study has showed RASSF10 significantly suppressed invasion or migration in HCC cell lines.